Back to search

Italy· 023105036

DEPAMIDE*30 cpr gastroresistenti 300 mg

A valpromide product containing valpromide, registered in Italy by SANOFI Srl, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N03AG02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedDEPAMIDE*30 cpr gastroresistenti 300 …ATCN03AG02REGISTER NO.023105036PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Valpromide is registered in 2 of 19 countries.

Countries holding a registration under ATC N03AG02 (valpromide), each read from that country’s own register.

  • This record: Italy
  • 2 of them publish a price we can compare per daily dose

Valpromide · ATC N03AG02

2 / 19 countries

  • Franceprice
  • Italyprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valpromide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • Italy: $0.93 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Valpromide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • IT Italy$0.93
  • FR France$0.79
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Valpromide
Manufacturer
SANOFI Srl
Country
Italy (IT)
ATC code
N03AG02
ATC class
Valpromide
Defined daily dose
1.5 g, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    023105036
    DEPAMIDE*30 cpr gastroresistenti 300 mg
    EUR 4.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Valpromide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valpromide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Depamide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3b432c3-cfb3-47a0-9f39-042a3322a247
GET /v1/drugs/d3b432c3-cfb3-47a0-9f39-042a3322a247?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 4.88,
  "source": "aifa",
  "currency": "EUR",
  "strength": "VALPROMIDE 300MG 30 UNITA' USO ORALE",
  "substance": "Valpromide",
  "equivalence_group": "T8A",
  "transparency_flag": null
}

See everything about valpromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.